Effect of MK-801 at the human α7 nicotinic acetylcholine receptor

Neuropharmacology

Volumn 35, Issue 4, 1996, Pages 407-414

  Briggs, Clark A ^a   McKenna, David G ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

acetylcholine; Acetylcholine nicotinic receptor; human; methyllycaconitine; MK 801; oocytes; Xenopus laevis; 7 nicotinic receptor

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; ATROPINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIZOCILPINE; MECAMYLAMINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ARTICLE; CHLORIDE CURRENT; DRUG EFFECT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SCREENING; STEREOCHEMISTRY; XENOPUS LAEVIS;

EID: 0029893705     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(96)00006-8     Document Type: Article

References (49)

1. Adler L. E., Hoffer L. J., Griffith J., Waldo M. C. and Freedman R. (1992) Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry 32: 607-616.
2. Akaike A., Tamura Y., Yokota T., Shimohama S. and Kimura J. (1994) Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res. 644: 181-187.
3. Alkondon M., Pereira E. F. R., Wonnacott S. and Albuquerque E. X. (1992) Blockade of nicotinic currents in hippocampal neurons defines methyllycaconkine as a potent and specific receptor antagonist. Molec. Pharmacol. 41: 802-808.
4. Amador M. and Dani J. A. (1991) MK-801 inhibition of nicotinic acetyicholine receptor channels. Synapse 7: 207-215.
5. Anand R., Peng X. and Lindstrom J. (1993) Homomeric and native α7 acetyicholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex. FEDS Lett. 327: 241-246.
6. Briggs C. A., Hughes M. L., Monteggia L. M., Giordano T., Donnelly-Roberts D. and Arneric S. P. (1995a) Ganglionic nicotinic acetylcholine receptor activation by the novel agonist ABT-418. Drug Dev. Res. 34: 39-46.
7. Briggs C. A., McKenna D. G. and Piattoni-Kaplan M. (1995b) Human α7 nicotinic acetyicholine receptor responses to novel ligands. Neuropharmacol. 34: 583-590.
8. Castro N. G. and Albuquerque E. X. (1995) α-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability. Biophys. J. 68: 516-524.
9. Chan J. and Quik M. (1993) A role nicotinic a-bungarotoxin receptor in neurite outgrowth in PC12 cells. Neuroscience 56: 441-451.
10. +. Br. J. Pharmacol. 114: 315-322.
11. Connolly J., Boulter J. and Heinemann S. F. (1992) α4-2β2 And other nicotinic acetyicholine receptor subtypes as targets of psychoactive and addictive drugs. Br. J. Pharmacol. 105: 657-666.
12. Couturier S., Bertrand D., Matter J.-M., Hernandez M.-C, Bertrand S., Millar N., Valera S., Barkas T. and Ballivet M. (1990) A neueronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homooligomeric channel blocked by α-BTX. Neuron 5: 847-856.
13. Daly J. W., Nishizawa Y., Edwards M. W., Waters J. A. and Aronstam R. S. (1991) Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers. Neurochem. Res. 16: 489-500.
14. Doucette-Stamm L., Monteggia L. M., Donnelly-Roberts D., Wang M. T., Lee J., Tian J. and Giordano T. (1993) Cloning and sequence of the human α7 nicotinic acetylcholine receptor. Drug Dev. Res. 30: 252-256.
15. el-Bizri H. and Clarke P. B. S. (1994) Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br. J. Pharmacol. 111: 406-413.
16. Freeman J. A. (1977) Possible regulatory function of acetylcholine receptor in maintenance of retinotectal synapses. Nature 269: 218-222.
17. Fuxe K., Rosén L., Lippoldt A., Andbjer B., Hasselrot U., Finnman U.-B. and Agnati L. F. (1994) Chronic continuous infusion of nicotine increases the disappearance of choline acetyltransferase immunoreactivity in the cholinergic cell bodies of the medial septal nucleus following a partial unilateral transection of the fimbria fornix. Clin. Invest. 72: 262-268.
18. Galligan J. J. and North R. A. (1990) MK-801 blocks nicotinic depolarizations of guinea pig myenteric neurons. Neurosci. Lett. 108: 105-109.
19. Gotti C., Hanke W., Maury K., Moretti M., Ballivet M., Clementi F. and Bertrand D. (1994) Pharmacology and biophysical properties of α7 and α7-α8 α-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur. J. Neurosci. 6: 1281-1291.
20. Halliwell R. F., Peters J. A. and Lambert J. J. (1989) The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture. Br. J. Pharmacol. 96: 480-494.
21. Huettner J. E. and Bean B. P. (1988) Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels. Proc. natn. Acad. Sci. U.S.A. 85: 1307-1311.
22. Janson A. M. and Moller A. (1993) Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience 57: 931-941.
23. Kavanaugh M. P., Tester B. A. and Weber E. (1989) Interaction of MK-801 with the nicotinic acetylcholine receptor-associated ion channel from electroplax. Eur. J. Pharmacol. 164: 397-398.
24. Kochhar A., Zivin J. A. and Mazzarella V. (1991) Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia. J. Neurotrauma 8: 175-186.
25. Lipton S. A. and Rosenberg P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330: 613-622.
26. Lukas R. J. (1989) Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastom J. Pharmacol. Exp. Ther. 251: 175-182.
27. Lynch D. R., Anegawa N. J., Yerdoorn T. and Pritchett D. B. (1994) N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Molec. Pharmacol. 45: 540-545.
28. Martin E. J., Panickar K. S., King M. A., Deyrup M., Hunter B. E., Wang G. H. and Meyer E. M. (1994) Cytoprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons. Drug Dev. Res. 31: 135-141.
29. McGehee D. S. and Role L. W. (1995) Physiological diversity of mcotmic acetyicholine receptors expressed by vertebrate neurons. A. Rev. Physiol. 57: 521-546.
30. McKenna D. G., Arneric S. P. and Briggs C. A. (1995) Inhibition of the human α7 nicotinic receptor by MK-801 (dizocilpine). Soc. Neurosci. Abstr. 21: 606.
31. Mulle C. and Changeux J.-P. (1990) A novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp techniques. J. Neurosci. 10: 169-175.
32. Nabeshima T., Yoshida S., Morinaka H., Kameyama T., Thurkauf A., Rice K. C., Jacobson A. E., Monn J. A. and Cho A. K. (1990) MK-801 ameliorates delayed amnesia, but potentiates acute amnesia induced by CO. Neurosci. Lett. 108: 321-327.
33. Peng X., Katz M., Gerzanich V., Anand R. and Lindstrom J. (1994) Human α7 acetylcholine receptor: Cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and function α7 homomers expressed in Xenopus oocytes. Molec. Pharmacol. 45: 546-554.
34. Peters J. A., Malone H. M. and Lambert J. J. (1990) Antagonism of 5-HT3 receptor mediated currents in murine N1E-115 neuroblastoma cells by (+)-tubocurarine. Neurosci. Lett. 110: 107-112.
35. Pugh P. C. and Berg D. K. (1994) Neuronal acetyleholine receptors that bind α-bungarotoxin mediate neutrite retraction in a calcium-dependent manner. J. Neurosci. 14: 889-896.
36. Quik M., Chan J. and Patrick J. (1994) α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res. 655: 161-167.
37. Ramoa A. S., Alkondon M., Aracava Y., Irons J., Lunt G. G., Deshpande S. S., Wonnacott S., Aronstam R. S. and Albuquerque E. X. (1990) The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetyleholine receptor ion channels. J. Pharmacol. exp. Ther. 254: 71-82.
38. Rogers M. and Dani J. A. (1995) Comparison of quantitative calcium flux through NMDA, ATP and ACh receptor channels. Biophys. J. 68: 501-509.
39. 3H]MK-801 binding sites determined by quantitative autoradiography in rat brain. Neuroscience 40: 533-543.
40. Sands S. B., Costa A. C. S. and Patrick J. W. (1993) Barium permeability of neuronal nicotinic receptor α7 expressed in Xenopus oocytes. Biophys. J. 65: 2614-2621.
41. 125I-neuronal bungarotoxin. J. Neurosci. 11: 287-297.
42. Stolerman I. P., Albuquerque E. X. and Garcha H. S. (1992) Behavioural effects of anatoxin, a potent nicotinic agonist, in rats. Neuropharmacology 31: 311-314.
43. Séguéla P., Wadiche J., Dineley-Miller K., Dani J. A. and Patrick J. W. (1993) Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium. J. Neurosci. 13: 596-604.
44. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J. Neurochem. 50: 274-81.
45. Wong E. H. F. and Kemp J. A. (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. A. Rev. Pharmacol. Toxicol. 31: 401-425.
46. Wright S. C., Zhong J., Zheng H. and Larrick J. W. (1993) Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J. 7: 1045-1051.
47. + flux from differentiated PC12 cells. Neurosci. Lett. 147: 97-100.
48. Zhang X., Gong Z.-H. and Nordberg A. (1994a) Effects of chronic treatment with (+)- and (-)-nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain. Brain Res. 644: 32-39.
49. Zhang Z., Vijayaraghavan S. and Berg D. K. (1994b) Neuronal acetylcholine receptors that bind α-bungarotoxin with high affinity function as ligand-gated ion channels. Neuron. 12: 167-177.